How ThermoPest Bed Bug Treatment London Combines Speed, Safety, and Reliability

London, UK – ThermoPest Bed Bug Treatment London eliminates stubborn bed bug infestations with unmatched precision and efficiency. The company specialises in advanced heat treatments that provide a comprehensive solution to infestations, removing the need for repeated chemical applications while delivering results in a single visit. In a city where bed bugs are a persistent […]

New Innovations On The Horizon For Winnipeg Dentist In 2025

WINNIPEG, MB: Fresh Dental, a leading Winnipeg dental clinic with two thriving locations, is approaching the end of a successful year with an eye to the future. As the start of 2025 draws near, the Fresh Dental team looks forward to the possibility of expanding its already extensive patient services in innovative and exciting new

Meyers Nave and Sohagi Law Group Combine

LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) — Meyers Nave announced today that it has joined forces with The Sohagi Law Group (SLG), a California boutique environmental and land use law firm, effective February 1. SLG Founder and Managing Partner Margaret Sohagi, Partner Nicole Hoeksma Gordon, Partner R. Tyson Sohagi, Senior Of Counsel, Albert I.

Shareholders that lost money on Pacira BioSciences, Inc. (PCRX) should contact Levi & Korsinsky about pending Class Action – PCRX

(NASDAQ:PCRX), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2,

Shareholders of Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SAVA

(NASDAQ:SAVA), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. (“Cassava Sciences, Inc.” or the “Company”) (NASDAQ: SAVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cassava Sciences, Inc. investors who were adversely affected by alleged securities

Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

(NASDAQ:REGN), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2,

Match Group, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MTCH

(NasdaqGM:MTCH), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Match Group, Inc. (“Match Group, Inc.” or the “Company”) (NASDAQ: MTCH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Match Group, Inc. investors who were adversely affected by alleged securities

AZN LAWSUIT ALERT: Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline

(NASDAQ:AZN), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022

January 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CUBI

(NYSE:CUBI), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Customers Bancorp, Inc. (“Customers Bancorp, Inc.” or the “Company”) (NYSE: CUBI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Customers Bancorp, Inc. investors who were adversely affected by alleged securities

Investors in Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights – RVNC

(NasdaqGM:RVNC), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29,

Scroll to Top